㽶Ƶ News - Andrew Karaplis /channels/news_feeds/all/term/Andrew%20Karaplis/rss en Clinical trial of novel approach to treating osteoporosis represents “significant breakthrough,” according to clinician-scientist at the Lady Davis Institute /channels/channels/news/clinical-trial-novel-approach-treating-osteoporosis-represents-significant-breakthrough-according-283574 <div class="field field-name-body field-type-text-with-summary field-label-hidden"><div class="field-items"><div class="field-item even"><p>A regimen of a novel bone anabolic medication (which builds bone mass) followed by an antiresorptive agent (which maintains bone mass) has been shown to significantly reduce the risk of fracture among post-menopausal women with severe osteoporosis, according to results of a clinical trial published in <em>The New England Journal of Medicine</em>.</p></div></div></div><div class="field field-name-field-published-date field-type-datestamp field-label-hidden"><div class="field-items"><div class="field-item even"><div class="custom-multi-date"><div class="multi-date first"><span class="label">Published: </span><span class="day">21 </span><span class="month">December </span><span class="year">2017</span></div></div></div></div></div> Thu, 21 Dec 2017 20:06:49 +0000 webfull 133747 at /channels